Cyagen Biosciences vs IPM Biotech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/apac-cyagen/ipmbiotech

Category	Cyagen Biosciences	IPM Biotech
Listed site	cro	cro
Summary	Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.	IPM Biotech (生创精准医疗科技有限公司) is a cell technology and regenerative medicine company founded in 2015 by a team of renowned returnee scientists specializing in stem cells and regenerative medicine.
Services	Specialized & Large-Animal Models Preclinical In Vivo Studies Preclinical In Vitro Studies In Vivo Efficacy Models Translational Research Discovery Research	Translational Research Clinical Trial Services Protein Engineering Discovery Research
Modalities	Biologics (Monoclonal Antibodies) Oligonucleotide Cell Therapy Gene Therapy AAV / Viral Vector Platform	Cell Therapy
Indications	Oncology Immunology Neurology Metabolic Rare Disease Ophthalmology	Oncology Immunology Neurology Metabolic Cardiovascular
Locations	Headquarters, Santa Clara, California, United States	Headquarters, Hangzhou, Zhejiang, China Xiaoshan Office, Hangzhou, Zhejiang, China Gongshu Office, Hangzhou, Zhejiang, China Zhoushan Facility, Zhoushan, Zhejiang, China Boao Facility, Qionghai, Hainan, China Bangkok Facility, Bangkok, Bangkok, Thailand Chongqing, Chongqing, Chongqing, China Jinan, Jinan, Shandong, China Zhengzhou, Zhengzhou, Henan, China Hong Kong, Hong Kong, Hong Kong, Hong Kong
Certifications	AAALAC · Identifier: AAALAC-accredited facilities	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.